Allianz Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.26B | Buy |
6,529,961
+6,528,003
| +333,402% | +$1.26B | 1.33% | 9 |
|
|
2025
Q4 | $360K | Buy |
1,958
+605
| +45% | +$106K | ﹤0.01% | 1877 |
|
|
2025
Q3 | $208K | Buy |
+1,353
| New | +$205K | ﹤0.01% | 1951 |
|
|
2024
Q4 | – | Sell |
-4,494
| Closed | -$700K | – | 2213 |
|
|
2024
Q3 | $700K | Buy |
4,494
+1,366
| +44% | +$221K | ﹤0.01% | 1759 |
|
|
2024
Q2 | $488K | Buy |
3,128
+1,472
| +89% | +$222K | ﹤0.01% | 1843 |
|
|
2024
Q1 | $224K | Buy |
+1,656
| New | +$219K | ﹤0.01% | 1827 |
|
|
2022
Q3 | – | Sell |
-849,844
| Closed | -$112M | – | 1896 |
|
|
2022
Q2 | $112M | Sell |
849,844
-1,342
| -0.2% | -$176K | 0.11% | 212 |
|
|
2022
Q1 | $113M | Buy |
851,186
+223,517
| +36% | +$26.8M | 0.08% | 253 |
|
|
2021
Q4 | $73.1M | Sell |
627,669
-7,614
| -1% | -$896K | 0.05% | 390 |
|
|
2021
Q3 | $76.3M | Buy |
635,283
+135,792
| +27% | +$15.8M | 0.06% | 338 |
|
|
2021
Q2 | $59.8M | Sell |
499,491
-272,437
| -35% | -$29.9M | 0.05% | 353 |
|
|
2021
Q1 | $76.8M | Sell |
771,928
-11,630
| -1% | -$1.17M | 0.07% | 269 |
|
|
2020
Q4 | $78.3M | Sell |
783,558
-8,260
| -1% | -$875K | 0.08% | 255 |
|
|
2020
Q3 | $86.8M | Buy |
791,818
+4,164
| +0.5% | +$463K | 0.1% | 207 |
|
|
2020
Q2 | $83.3M | Sell |
787,654
-1,321
| -0.2% | -$136K | 0.1% | 221 |
|
|
2020
Q1 | $70.5M | Sell |
788,975
-92,763
| -11% | -$8.73M | 0.09% | 229 |
|
|
2019
Q4 | $87.9M | Sell |
881,738
-45,878
| -5% | -$4.32M | 0.08% | 270 |
|
|
2019
Q3 | $82.7M | Buy |
927,616
+672,813
| +264% | +$58.3M | 0.08% | 271 |
|
|
2019
Q2 | $21M | Buy |
254,803
+27,637
| +12% | +$2.17M | 0.02% | 790 |
|
|
2019
Q1 | $18.4M | Buy |
227,166
+74,205
| +49% | +$5.85M | 0.02% | 794 |
|
|
2018
Q4 | $11.6M | Sell |
152,961
-49
| -0% | -$3.83K | 0.01% | 1042 |
|
|
2018
Q3 | $12.1M | Buy |
153,010
+106,802
| +231% | +$8.08M | 0.01% | 1177 |
|
|
2018
Q2 | $3.25M | Buy |
46,208
+300
| +0.7% | +$21.6K | ﹤0.01% | 1730 |
|
|
2018
Q1 | $3.21M | Sell |
45,908
-2,290
| -5% | -$159K | ﹤0.01% | 1724 |
|
|
2017
Q4 | $3.35M | Buy |
48,198
+9,149
| +23% | +$617K | ﹤0.01% | 1797 |
|
|
2017
Q3 | $2.65M | Sell |
39,049
-23,263
| -37% | -$1.47M | ﹤0.01% | 1898 |
|
|
2017
Q2 | $4.25M | Sell |
62,312
-51,615
| -45% | -$3.37M | ﹤0.01% | 1665 |
|
|
2017
Q1 | $7.09M | Sell |
113,927
-35,077
| -24% | -$2.04M | 0.01% | 1478 |
|
|
2016
Q4 | $8.14M | Buy |
149,004
+60,387
| +68% | +$3.43M | 0.01% | 1448 |
|
|
2016
Q3 | $5.86M | Sell |
88,617
-20,497
| -19% | -$1.34M | 0.01% | 1558 |
|
|
2016
Q2 | $6.59M | Sell |
109,114
-16,942
| -13% | -$984K | 0.01% | 1390 |
|
|
2016
Q1 | $7.1M | Buy |
126,056
+42,980
| +52% | +$2.58M | 0.01% | 1301 |
|
|
2015
Q4 | $5.64M | Buy |
+83,076
| New | +$5.45M | 0.01% | 1305 |
|
|
2014
Q4 | – | Sell |
-105,014
| Closed | -$7.5M | – | 2345 |
|
|
2014
Q3 | $7.5M | Sell |
105,014
-126
| -0.1% | -$9.22K | 0.01% | 935 |
|
|
2014
Q2 | $7.81M | Sell |
105,140
-8,594,328
| -99% | -$621M | 0.01% | 810 |
|
|
2014
Q1 | $564M | Sell |
8,699,468
-1,712,015
| -16% | -$111M | 0.68% | 24 |
|
|
2013
Q4 | $618M | Sell |
10,411,483
-293,558
| -3% | -$15.9M | 0.79% | 18 |
|
|
2013
Q3 | $556M | Sell |
10,705,041
-2,138,081
| -17% | -$107M | 0.74% | 23 |
|
|
2013
Q2 | $607M | Buy |
+12,843,122
| New | +$654M | 0.86% | 15 |
|
Other funds holding AZN
IA
VCM
VAM
Allianz Asset Management's AZN Position: Q1 2026 in Review
Allianz Asset Management increased its AstraZeneca (AZN) stake by 333,402% in Q1 2026, buying an estimated $1.26B and bringing the position to 6,529,961 shares worth $1.26B. The position accounts for 1.33% of the portfolio, ranked #9.
Allianz Asset Management first reported a position in AZN in Q2 2013 and has held it in 39 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Allianz Asset Management held 6,529,961 shares of AstraZeneca worth $1.26B as of Q1 2026.
- Allianz Asset Management bought 6,528,003 AstraZeneca shares in Q1 2026, an estimated $1.26B.
- AstraZeneca made up 1.33% of Allianz Asset Management's portfolio in Q1 2026, its #9 holding.
- Allianz Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 39 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.